Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM)

PURPOSE: Buprenorphine transdermal system is increasingly prescribed in people with advanced dementia, but no clinical trial has investigated the safety and factors associated with discontinuation due to adverse events in this population. PATIENTS AND METHODS: One hundred sixty-two people with advan...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdal, Ane, Flo, Elisabeth, Aarsland, Dag, Selbaek, Geir, Ballard, Clive, Slettebo, Dagrun D, Husebo, Bettina S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960239/
https://www.ncbi.nlm.nih.gov/pubmed/29805252
http://dx.doi.org/10.2147/CIA.S161052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960239/
https://www.ncbi.nlm.nih.gov/pubmed/29805252
http://dx.doi.org/10.2147/CIA.S161052

Ejemplares similares